Showing results (141-150 of 462) with videos related to
Sort By:
Pageof 47
British Journal of Clinical Pharmacology|October 20, 2020
Warfarin dosing algorithms: A systematic reviewInnocent G Asiimwe, Eunice J Zhang, Rostam Osanlou, et al.Frontiers in Pharmacology|September 18, 2023
Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene studyLaurence McEvoy, Joanne Cliff, Daniel F Carr, et al.British Journal of Clinical Pharmacology|March 16, 2026
Consistency and clarity of pharmacogenomic guidance in UK medicine patient information leaflets: A cross-sectional analysisParth Narlawar, Chloe Ratcliffe, Videha Sharma, et al.British Journal of Clinical Pharmacology|April 27, 2025
Implementation of mass pharmacogenetic testing: Dihydropyrimidine dehydrogenase testing prior to fluoropyrimidine treatment for patientsNisha Shaunak, Jessica Keen, Anna Kim, et al.Lancet (London, England)|April 25, 2003
Reporting of adverse drug reactions by nursesSally Morrison-Griffiths, Thomas J Walley, B Kevin Park, et al.Plos One|April 1, 2017
Epidemiology of alcohol dependence in UK primary care: Results from a large observational study using the Clinical Practice Research DatalinkAndrew Thompson, Alison K Wright, Darren M Ashcroft, et al.Pharmacogenetics and Genomics|February 26, 2015
HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysisElena M Cornejo Castro, Daniel F Carr, Andrea L Jorgensen, et al.British Journal of Clinical Pharmacology|November 3, 2010
Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admissionEmma C Davies, Christopher F Green, David R Mottram, et al.Scientific Reports|March 25, 2018
Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated LipocalinStephen J McWilliam, Daniel J Antoine, Andrea L Jorgensen, et al.Pediatric Nephrology (Berlin, Germany)|August 20, 2017
Identifying cisplatin-induced kidney damage in paediatric oncology patientsChris D Barton, Barry Pizer, Caroline Jones, et al.Pageof 47